Patient Derived Organoid-guided Personalized Treatment Versus Treatment of Physician's Choice in Breast Cancer

After the organoid culture is successful, the personalized drug library customized by our team will be used for screening. Sensitive drugs are selected based on the results of drug screening, and the most appropriate personalized treatment plan is selected based on NCCN guideline recommendations, drug safety, and conventional drugs used in the treatment of breast cancer. The personalized drug library customized by our team contains 55 drugs approved by the FDA. For specific usage, dosage and time intervals, please refer to the instructions of the corresponding drug.

1000mg/m2，IV, days 1, 8, q3w

1000mg/m² , PO, bid, days1-14, q3w

25mg/m2, IV or 60mg/m² (oral), days 1 and 8, q3w

1.4mg/m², IV, days 1 and 8, q3w